These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1608895)

  • 21. The technical transition to CFC-free inhalers.
    Tansey I
    Br J Clin Pract Suppl; 1997 May; 89():22-7. PubMed ID: 9519509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Switching patients with asthma from chlorofluorocarbon (CFC) albuterol to hydrofluoroalkane-134a (HFA) albuterol.
    Bronsky E; Ekholm BP; Klinger NM; Colice GL
    J Asthma; 1999; 36(1):107-14. PubMed ID: 10077140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of formulation and spacer device on the in vitro performance of solution chlorofluorocarbon-free propellant-driven metered dose inhalers.
    Smyth HD; Beck VP; Williams D; Hickey AJ
    AAPS PharmSciTech; 2004 Feb; 5(1):E7. PubMed ID: 15198528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aerosol generation by metered-dose inhalers containing dimethyl ether/propane inverse microemulsions.
    Sommerville ML; Hickey AJ
    AAPS PharmSciTech; 2003 Nov; 4(4):E58. PubMed ID: 15198553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An overview of environmental hazards and exposure risk of hydrofluorocarbons (HFCs).
    Tsai WT
    Chemosphere; 2005 Dec; 61(11):1539-47. PubMed ID: 15936055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polystyrene microsphere spray standards based on CFC-free inhaler technology.
    Vervaet C; Byron PR
    J Aerosol Med; 2000; 13(2):105-15. PubMed ID: 11010591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhalational drug delivery from seven different spacer devices.
    Barry PW; O'Callaghan C
    Thorax; 1996 Aug; 51(8):835-40. PubMed ID: 8795674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimized dose delivery of the peptide cyclosporine using hydrofluoroalkane-based metered dose inhalers.
    Myrdal PB; Karlage KL; Stein SW; Brown BA; Haynes A
    J Pharm Sci; 2004 Apr; 93(4):1054-61. PubMed ID: 14999741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Propellant gases in metered dose inhalers: their impact on the global environment.
    Balmes JR
    Respir Care; 1991 Sep; 36(9):1037-44. PubMed ID: 10145537
    [No Abstract]   [Full Text] [Related]  

  • 30. A novel formulation technique for metered dose inhaler (MDI) suspensions.
    Steckel H; Wehle S
    Int J Pharm; 2004 Oct; 284(1-2):75-82. PubMed ID: 15454299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The equivalent bronchodilator effects of salbutamol formulated in chlorofluorocarbon and hydrofluoroalkane-134a metered dose inhalers on the histamine-induced pulmonary response in dogs.
    Nogami-Itoh M; Yakuo I; Hammerbeck DM; Miller RL; Takeyama K
    Pharm Res; 1997 Feb; 14(2):208-12. PubMed ID: 9090711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic exposure to fluticasone propionate administered via metered-dose inhaler containing chlorofluorocarbon or hydrofluoroalkane propellant.
    Mackie AE; McDowall JE; Ventresca P; Bye A; Falcoz C; Daley-Yates PT
    Clin Pharmacokinet; 2000; 39 Suppl 1():17-22. PubMed ID: 11140429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delivery of fenoterol via Respimat, a novel 'soft mist' inhaler. a randomised, double-blind (within device), placebo-controlled, cross-over, dose-ranging study in asthmatic patients.
    van Noord JA; Smeets JJ; Creemers JP; Greefhorst LP; Dewberry H; Cornelissen PJ
    Respiration; 2000; 67(6):672-8. PubMed ID: 11124651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Possible replacements for CFC-propelled metered-dose inhalers.
    Dalby RN
    Med Device Technol; 1991 May; 2(4):21-5. PubMed ID: 10149436
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of metered dose inhaler (MDI) formulations of ciclosporin.
    Marijani R; Shaik MS; Chatterjee A; Singh M
    J Pharm Pharmacol; 2007 Jan; 59(1):15-21. PubMed ID: 17227616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in metered dose inhaler technology with the development of a chlorofluorocarbon-free drug delivery system.
    Ross DL; Gabrio BJ
    J Aerosol Med; 1999; 12(3):151-60. PubMed ID: 10623331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early lung absorption profile of non-CFC salbutamol via small and large volume plastic spacer devices.
    Lipworth BJ; Clark DJ
    Br J Clin Pharmacol; 1998 Jul; 46(1):45-8. PubMed ID: 9690948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minimum ignition energies and laminar burning velocities of ammonia, HFO-1234yf, HFC-32 and their mixtures with carbon dioxide, HFC-125 and HFC-134a.
    Sadaghiani MS; Arami-Niya A; Zhang D; Tsuji T; Tanaka Y; Seiki Y; May EF
    J Hazard Mater; 2021 Apr; 407():124781. PubMed ID: 33412363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhalation of single vs multiple metered-dose bronchodilator actuations from reservoir devices. An in vitro study.
    Rau JL; Restrepo RD; Deshpande V
    Chest; 1996 Apr; 109(4):969-74. PubMed ID: 8635379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salmeterol HFA is as effective as salmeterol CFC in children and adults with persistent asthma.
    Chopra N; Williams M; Rimmer M; Kahl L; Jenkins M;
    Respir Med; 2005 Apr; 99 Suppl A():S1-S10. PubMed ID: 15777603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.